Navigation Links
Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation
Date:6/30/2010

CLEVELAND, Ohio, June 30, 2010 /PRNewswire/ -- Simbionix Ltd., a subsidiary of Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, and USF Health, an organization dedicated to creating a model of health care based on understanding the full spectrum of health, are proud to announce that together they received a BIRD (Binational Industrial Research and Development) Grant to support the development of a Laparoscopic Hysterectomy simulation module.

The BIRD Foundation was established by the U.S. and Israeli governments in 1977 to generate mutually beneficial cooperation between the private sectors of the U.S. and Israeli high tech industries, including start-ups and established organizations. BIRD provides both matchmaking services between U.S. and Israeli companies, as well as funding covering up to 50 percent of project development and initial product commercialization costs.

Developing this new Laparoscopic Hysterectomy module supports Simbionix' goal for including complex advanced procedures in their comprehensive LAP Mentor(TM) Simulator. It also reaffirms Simbionix' commitment towards improving the quality of care in the field of Women's Health. Approximately 600,000 hysterectomies are performed annually in the US, making it the second most frequently performed major surgical procedure. The Laparoscopic Hysterectomy procedure requires greater surgical skills than the vaginal and abdominal methods, and as such necessitates performing approximately 15 procedures before surgeons become proficient. Since this procedure is difficult to teach using conventional methods, practicing Ob-Gyns may have never received laparoscopic training during their residency. The new module will use medical simulation teaching methods to provide the necessary complex skills acquisition and training for surgeons.

Dr. Stephen K. Klasko, CEO of USF Health and Dean of the USF College of Medicine stated: "As simulation technology expands its use as a driver for quality and safety in medicine, it will take great organizations working together. At USF Health, we have been a leader in applying technology to improve the health of our community. Over the past year, USF Health has had the opportunity to work with Simbionix, the world's leading provider of medical education and simulation products to deliver training for medical students, residents, practicing physicians and other healthcare professionals to enhance technical competence and improve patient outcomes. The award of the BIRD grant provides a fantastic opportunity for us to work with Simbionix to develop the first laparoscopic hysterectomy simulation module for training GYN surgeons in minimally invasive surgery techniques. This project has the potential to have a huge impact on the quality of practice of gynecologists worldwide. Through us working together, our doctors, our patients and the health of our communities will stand to be the winners."

"Simbionix makes it a priority to cooperate with the medical community on a regular basis for the advancement of medical education and training" says Simbionix President Ran Bronstein. "We are honored to have received this grant and to be working on this exciting project in conjunction with USF. Simbionix' unique, advanced simulation technology, combined with the clinical and educational expertise of USF Health's collaborating physicians, and USF Health's experience in integrating medical simulation into certifiable curricula, will ensure that the advanced GYN - Hysterectomy simulation module will truly be an innovative and critical contribution to improving women's healthcare."

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.

For more information on Simbionix, visit http://www.simbionix.com

About USF Health

USF Health (http://www.health.usf.edu) is dedicated to creating a model of health care based on understanding the full spectrum of health. It includes the University of South Florida's colleges of medicine, nursing, and public health; the schools of biomedical sciences as well as physical therapy & rehabilitation sciences; and the USF Physicians Group. With more than $380.4 million in research grants and contracts last year, the University of South Florida is one of the nation's top 63 public research universities and one of only 25 public research universities nationwide with very high research activity that is designated as community-engaged by the Carnegie Foundation for the Advancement of Teaching.

    Contact:
    Rebecca Zitter
    +1-216-2292040
    Manager of Marketing Communications and Distributor Relations
    Rebecca@simbionix.com



'/>"/>
SOURCE Simbionix Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Simbionix Welcomes Two New Members to Expand Compays Medical Education Product Offerings
2. Simbionix Introduces the Next Generation in Bronchoscopy Training
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. AMS Receives 510(k) Clearance of Its Revolutionary MoXy(TM) Liquid Cooled Fiber for Fast, Safe Treatment of Enlarged Prostate
5. Mylan Receives Approval for Generic Version of Arimidex® Tablets
6. Abbott Receives FDA Clearance for Molecular Diagnostic Test for Detection of Chlamydia and Gonorrhea Infections
7. Solta Medical Announces Thermage CPT™ and Fraxel re:store® Dual Systems Receive Health Canada Approval
8. Archimedes Pharma Receives CHMP Positive Opinion for PecFent(R) for the Treatment of Breakthrough Cancer Pain
9. Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
10. PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects
11. Mylan Receives Approval for Generic Version of Zocor® Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):